Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver Journal Article


Authors: Ammori, J. B.; Kemeny, N. E.
Article Title: Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver
Abstract: Colorectal cancer metastases to the liver are primarily supplied by the hepatic artery. Therefore, delivery of regional chemotherapy via the hepatic artery is a viable treatment option. Chemotherapy can be delivered in high concentration to the liver with minimal systemic toxicity. Hepatic artery infusional (HAI) chemotherapy both alone and in combination with systemic chemotherapy in the treatment of isolated hepatic metastases from colorectal cancer has resulted in high response rates and increased resection rates for previously unresectable liver disease. Regional chemotherapy can also be used as adjuvant treatment after complete resection of liver metastases to reduce hepatic recurrences. The combination of HAI therapy with modern systemic chemotherapy has a role in the palliative, adjuvant, and neoadjuvant settings. © 2010 Elsevier Inc. All rights reserved.
Keywords: cancer chemotherapy; unclassified drug; overall survival; clinical trial; neutropenia; fluorouracil; diarrhea; drug withdrawal; monotherapy; side effect; antineoplastic agents; clinical trials as topic; liver neoplasms; adjuvant therapy; disease free survival; outcome assessment; antineoplastic agent; colorectal cancer; interleukin 2; progression free survival; multiple cycle treatment; stomatitis; combination chemotherapy; dexamethasone; continuous infusion; irinotecan; colorectal neoplasms; liver metastasis; immunotherapy; folinic acid; adjuvant chemotherapy; thrombosis; infusions, intra-arterial; drug clearance; single drug dose; mitomycin c; liver surgery; drug metabolism; drug half life; drug substitution; oxaliplatin; floxuridine; hepatobiliary disease; primary health care; bischlorethylnitrosurea; arteritis; biliary tract disease
Journal Title: Seminars in Oncology
Volume: 37
Issue: 2
ISSN: 0093-7754
Publisher: Elsevier Inc.  
Date Published: 2010-04-01
Start Page: 139
End Page: 148
Language: English
DOI: 10.1053/j.seminoncol.2010.03.003
PUBMED: 20494706
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: SOLGA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John Brian Ammori
    9 Ammori
  2. Nancy Kemeny
    543 Kemeny